A poll commissioned by American Commitment, a conservative-leaning advocacy group, showed that 80 percent of older voters fear the prescription drug reforms included in President Biden’s landmark Inflation Reduction Act will negatively impact drug innovation while 14 percent of those voters think it will lower their drug costs.